189 related articles for article (PubMed ID: 15228755)
1. Measurement of whole-brain atrophy in multiple sclerosis.
Pelletier D; Garrison K; Henry R
J Neuroimaging; 2004 Jul; 14(3 Suppl):11S-19S. PubMed ID: 15228755
[TBL] [Abstract][Full Text] [Related]
2. Reproducibility and accuracy of quantitative magnetic resonance imaging techniques of whole-brain atrophy measurement in multiple sclerosis.
Zivadinov R; Grop A; Sharma J; Bratina A; Tjoa CW; Dwyer M; Zorzon M
J Neuroimaging; 2005 Jan; 15(1):27-36. PubMed ID: 15574571
[TBL] [Abstract][Full Text] [Related]
3. Measuring brain atrophy in multiple sclerosis.
De Stefano N; Battaglini M; Smith SM
J Neuroimaging; 2007 Apr; 17 Suppl 1():10S-15S. PubMed ID: 17425728
[TBL] [Abstract][Full Text] [Related]
4. Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis.
Battaglini M; Giorgio A; Stromillo ML; Bartolozzi ML; Guidi L; Federico A; De Stefano N
J Neurol Sci; 2009 Jul; 282(1-2):55-60. PubMed ID: 19286193
[TBL] [Abstract][Full Text] [Related]
5. Reduction of brain volume in MS. MRI and pathology findings.
Lycklama à Nijeholt GJ
J Neurol Sci; 2005 Jun; 233(1-2):199-202. PubMed ID: 15949505
[TBL] [Abstract][Full Text] [Related]
6. Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis.
Gordon-Lipkin E; Chodkowski B; Reich DS; Smith SA; Pulicken M; Balcer LJ; Frohman EM; Cutter G; Calabresi PA
Neurology; 2007 Oct; 69(16):1603-9. PubMed ID: 17938370
[TBL] [Abstract][Full Text] [Related]
7. Quantitative diffusion weighted imaging measures in patients with multiple sclerosis.
Tavazzi E; Dwyer MG; Weinstock-Guttman B; Lema J; Bastianello S; Bergamaschi R; Cosi V; Benedict RH; Munschauer FE; Zivadinov R
Neuroimage; 2007 Jul; 36(3):746-54. PubMed ID: 17498974
[TBL] [Abstract][Full Text] [Related]
8. Clinical-magnetic resonance imaging correlations in multiple sclerosis.
Zivadinov R; Leist TP
J Neuroimaging; 2005; 15(4 Suppl):10S-21S. PubMed ID: 16385015
[TBL] [Abstract][Full Text] [Related]
9. Agreement between different input image types in brain atrophy measurement in multiple sclerosis using SIENAX and SIENA.
Neacsu V; Jasperse B; Korteweg T; Knol DL; Valsasina P; Filippi M; Barkhof F; Rovaris M; Vrenken H;
J Magn Reson Imaging; 2008 Sep; 28(3):559-65. PubMed ID: 18777529
[TBL] [Abstract][Full Text] [Related]
10. Measurement of brain and spinal cord atrophy by magnetic resonance imaging as a tool to monitor multiple sclerosis.
Bakshi R; Dandamudi VS; Neema M; De C; Bermel RA
J Neuroimaging; 2005; 15(4 Suppl):30S-45S. PubMed ID: 16385017
[TBL] [Abstract][Full Text] [Related]
11. Measurement of brain atrophy in subcortical vascular disease: a comparison of different approaches and the impact of ischaemic lesions.
O'Sullivan M; Jouvent E; Saemann PG; Mangin JF; Viswanathan A; Gschwendtner A; Bracoud L; Pachai C; Chabriat H; Dichgans M
Neuroimage; 2008 Nov; 43(2):312-20. PubMed ID: 18722537
[TBL] [Abstract][Full Text] [Related]
12. Multiprotocol MR image segmentation in multiple sclerosis: experience with over 1,000 studies.
Udupa JK; Nyúl LG; Ge Y; Grossman RI
Acad Radiol; 2001 Nov; 8(11):1116-26. PubMed ID: 11721811
[TBL] [Abstract][Full Text] [Related]
13. Relationship of optic nerve and brain conventional and non-conventional MRI measures and retinal nerve fiber layer thickness, as assessed by OCT and GDx: a pilot study.
Frohman EM; Dwyer MG; Frohman T; Cox JL; Salter A; Greenberg BM; Hussein S; Conger A; Calabresi P; Balcer LJ; Zivadinov R
J Neurol Sci; 2009 Jul; 282(1-2):96-105. PubMed ID: 19439327
[TBL] [Abstract][Full Text] [Related]
14. Gray matter atrophy in multiple sclerosis: a longitudinal study.
Fisher E; Lee JC; Nakamura K; Rudick RA
Ann Neurol; 2008 Sep; 64(3):255-65. PubMed ID: 18661561
[TBL] [Abstract][Full Text] [Related]
15. Contribution of white matter lesions to gray matter atrophy in multiple sclerosis: evidence from voxel-based analysis of T1 lesions in the visual pathway.
Sepulcre J; Goñi J; Masdeu JC; Bejarano B; Vélez de Mendizábal N; Toledo JB; Villoslada P
Arch Neurol; 2009 Feb; 66(2):173-9. PubMed ID: 19204153
[TBL] [Abstract][Full Text] [Related]
16. Disease modeling in multiple sclerosis: assessment and quantification of sources of variability in brain parenchymal fraction measurements.
Sampat MP; Healy BC; Meier DS; Dell'Oglio E; Liguori M; Guttmann CR
Neuroimage; 2010 Oct; 52(4):1367-73. PubMed ID: 20362675
[TBL] [Abstract][Full Text] [Related]
17. T1- and T2-based MRI measures of diffuse gray matter and white matter damage in patients with multiple sclerosis.
Neema M; Stankiewicz J; Arora A; Dandamudi VS; Batt CE; Guss ZD; Al-Sabbagh A; Bakshi R
J Neuroimaging; 2007 Apr; 17 Suppl 1():16S-21S. PubMed ID: 17425729
[TBL] [Abstract][Full Text] [Related]
18. Brain volumetry counterparts of cognitive impairment in patients with multiple sclerosis.
Sastre-Garriga J; Arévalo MJ; Renom M; Alonso J; González I; Galán I; Montalban X; Rovira A
J Neurol Sci; 2009 Jul; 282(1-2):120-4. PubMed ID: 19157420
[TBL] [Abstract][Full Text] [Related]
19. One-dimensional-ratio measures of atrophy progression in multiple sclerosis as evaluated by longitudinal magnetic resonance imaging.
Martola J; Stawiarz L; Fredrikson S; Hillert J; Bergström J; Flodmark O; Aspelin P; Wiberg MK
Acta Radiol; 2009 Oct; 50(8):924-32. PubMed ID: 19639474
[TBL] [Abstract][Full Text] [Related]
20. Rate of brain atrophy in benign vs early multiple sclerosis.
Gauthier SA; Berger AM; Liptak Z; Duan Y; Egorova S; Buckle GJ; Glanz BI; Khoury SJ; Bakshi R; Weiner HL; Guttmann CR
Arch Neurol; 2009 Feb; 66(2):234-7. PubMed ID: 19204160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
